These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2637245)

  • 1. A pharmacological study of veratrine-induced hyperthermia in the rat: a model of neuroleptic malignant syndrome.
    Kato T; Yamawaki S
    Hiroshima J Med Sci; 1989 Dec; 38(4):173-81. PubMed ID: 2637245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine.
    Yamawaki S; Lai H; Horita A
    J Pharmacol Exp Ther; 1983 Nov; 227(2):383-8. PubMed ID: 6631720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
    Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Etiologic mechanism of neuroleptic malignant syndrome--hypothesis of dopamine-serotonin imbalance].
    Yamawaki N
    Seishin Shinkeigaku Zasshi; 1988; 90(10):869-76. PubMed ID: 3251270
    [No Abstract]   [Full Text] [Related]  

  • 5. Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome.
    Nisijima K; Shioda K; Yoshino T; Takano K; Kato S
    Pharmacopsychiatry; 2004 Mar; 37(2):57-62. PubMed ID: 15048612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxin-induced hyperthermic syndromes.
    Rusyniak DE; Sprague JE
    Med Clin North Am; 2005 Nov; 89(6):1277-96. PubMed ID: 16227063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of 2-(4-ethyl-1-piperazinyl)-4-(fluorophenyl)-5,6,7,8,9, 10-hexahydrocycloocta[b]pyridine (AD-5423) and haloperidol for their pharmacological activities related to antipsychotic efficacy and/or adverse side-effects.
    Noda Y; Kurumiya S; Miura Y; Oka M
    J Pharmacol Exp Ther; 1993 May; 265(2):745-51. PubMed ID: 8098763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome: mechanisms, interactions, and causality.
    Gillman PK
    Mov Disord; 2010 Sep; 25(12):1780-90. PubMed ID: 20623765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermoregulatory dysfunction in neuroleptic malignant syndrome.
    Gurrera RJ; Chang SS
    Biol Psychiatry; 1996 Feb; 39(3):207-12. PubMed ID: 8837982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
    Broening HW; Morford LL; Vorhees CV
    Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encephalopathy during amitriptyline therapy: are neuroleptic malignant syndrome and serotonin syndrome spectrum disorders?
    Miyaoka H; Kamijima K
    Int Clin Psychopharmacol; 1995 Nov; 10(4):265-7. PubMed ID: 8748050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of body temperature and thermoregulatory responses of freely moving rats during GABAergic pharmacological stimulation to the preoptic area and anterior hypothalamus in several ambient temperatures.
    Ishiwata T; Saito T; Hasegawa H; Yazawa T; Kotani Y; Otokawa M; Aihara Y
    Brain Res; 2005 Jun; 1048(1-2):32-40. PubMed ID: 15913569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome.
    Gurrera RJ
    Am J Psychiatry; 1999 Feb; 156(2):169-80. PubMed ID: 9989551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A serotonergic component in the central action of 1-(o-methoxyphenyl)-piperazine.
    Pawłowski L
    Pol J Pharmacol Pharm; 1983; 35(4):319-26. PubMed ID: 6664937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthermic syndromes induced by toxins.
    Rusyniak DE; Sprague JE
    Clin Lab Med; 2006 Mar; 26(1):165-84, ix. PubMed ID: 16567230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin(1A) receptor agonism in the expression of behavioral dopaminergic supersensitivity in subchronic haloperidol treated rats.
    Batool F; Haleem DJ
    Pak J Pharm Sci; 2008 Oct; 21(4):411-20. PubMed ID: 18930864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of succinylcholine and related substances administered into the medial preoptic area on the local EEG, body temperature, heart rate, galvanic skin resistance and biogenic amines.
    Rau M; Desiraju T
    Indian J Physiol Pharmacol; 1985; 29(4):185-98. PubMed ID: 3842371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.
    Darvesh AS; Gudelsky GA
    Neurotoxicol Teratol; 2004; 26(4):571-7. PubMed ID: 15203179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The malignant neuroleptic syndrome and malignant hyperthermia].
    Mitterschiffthaler G; Hackl JM; Neumann R
    Anaesthesist; 1989 Apr; 38(4):210-3. PubMed ID: 2729540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat loss during exercise is related to serotonin activity in the preoptic area.
    Rodrigues AG; Soares DD; Marubayashi U; Coimbra CC
    Neuroreport; 2009 May; 20(8):804-8. PubMed ID: 19369904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.